Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytotoxicity of CHS-828 enhanced in PARP-1-deficient mouse fibroblasts

Sep. 13, 2002

Pro-Pharmaceuticals to advance Davanat-1 into clinic in fourth quarter

Sep. 13, 2002

Antiproliferative effects of selenomethionine in human prostate cancer cells

Sep. 13, 2002

Leo reports cyclic phosphonamide MMP inhibitors with antitumor activity

Sep. 12, 2002

NV-1020 completes phase I in colorectal cancer metastatic to the liver

Sep. 12, 2002

Genta evaluates Genasense in children with solid tumors

Sep. 10, 2002

Novel antitumor compounds isolated from Clavularia corals

Sep. 9, 2002

Novel inhibitors of VEGF expression covered by Mercian patent

Sep. 9, 2002

Arimidex approved in early breast cancer

Sep. 9, 2002

Bay-43-9006 enters phase II

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...